In the era that most of the countries are moving toward universal health coverage (UHC), there is no doubt that every country experiences gap between their citizen’s health needs and what is economically achievable by government, especially in speedily advancement in health technology field. Hence p

The past 9th HTAsiaLink Annual Conference has been a big success, initiating the first hybrid conference in our HTAsiaLink history. However, unpredictable challenges still await, both existing and new coming issues. Omicron is one of them, provoking us to strive for more knowledge and evidence. As f

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

In the world that is full of unpredictable and countless number of uncertainties, it is a great challenge that we have to observe and adapt in order to overcome such swiftly shifting challenges. However, over the past three years, people around the world have been facing one of the most critic

Dive into real-world examples of how Health Technology Assessment (HTA) is making a difference—shaping healthcare policies, strengthening systems, and driving impact through collaboration and knowledge sharing.

Details: The 11th HTAsiaLink Annual Conference took place in Putrajaya Malaysia, centered around the theme “Reshaping and Reshifting HTA in Navigating the Future Landscape”. Key discussions revolved around accelerating access to technologies, evaluating public health interventions and addressing ch

Stories of knowledge translation: lessons learned from three years of experience working in a policy research unit under the Thai Ministry of Public Health Jomkwan Yothasamut Health Intervention and Technology Assessment Program, Thai Ministry of Public Health Introduction Quality reseach ca

Government use licenses in Thailand: The power of evidence, civil movement and political leadership Suwit Wibulpolprasert1, Vichai Chokevivat2, Cecilia Oh3 and Inthira Yamabhai3* 3Health Intervention and Technology Assessment Program Abstract This paper attempts to describe and analyse t

Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models Mark Jit1, Nadia Demarteau2†, Elamin Elbasha3†, Gary Ginsberg4†, Jane Kim5†, Naiyana Praditsitthikorn6†, Edina Sinanovic7† and Raymond Hutubessy8* † Contributed equally 8

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand Pattara Leelahavarong1*, Yot Teerawattananon1, Pitsaphun Werayingyong1, Chutima Akaleephan2, Nakorn Premsri3, Chawetsan Namwat3, Wiwat Peerapatanapoki